Updates

Inspecs

May 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Having bought Eisenbach (eyewear), Norville (lens maker), Ego (licenced eyewear) and BoDe (sunglasses) since its IPO in 2020, growing pains saw the shares drop off a cliff last year but in January, with the shares at just 42p, a tenth of the 400p high in October ‘21, I felt it was time to alight on them as things didn't look all that bad to me. I made the shares a NAP and have yet to write fully as management have been in hiding for most of the past few months fixing things. As the FY22 results reported last month show, the number of frames sold increased from 10.4m to 10.7m. Sales increased by 1% to US$248.6m (8.5% constant currency) and 2.5% organic. Adjusted pretax profit was US$8.1m for eps of 6.5 cents. Adjusted EBIT ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Made Tech - Record order book but government slow to start contracts

Growth Portfolio 3 - May '23

Inspecs - Large US business wins enhance H2 (October 2024)

Inspecs - Pretax profit guided to grow 22% to £9.9m (July 2024)

Inspecs - Q1 signals the corner is turned (May 2024)

Inspecs (February 2024)

Inspecs - Margins enhanced by moving Eschenbach acetate manufacture to Vietnam (January 2024)

Inspecs (October 2023)

Inspecs (August 2023)

Inspecs - EBITDA forecast to jump US$6m this year (July 2023)

Inspecs (February 2023)

Inspecs - Interesting new issue (March 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X